Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160002 · ClinicalTrials.gov registry record · NA
Incubator Weaning of Moderately Preterm Infants
A NA study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- NA
- Development phase
- 366
- Enrollment target
NCT02160002: Completed NA study, sponsored by NICHD Neonatal Research Network.
NCT02160002 is a NA study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 366 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02160002, a NA study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 366 participants
- Enrollment target
Study Summary
The objective of this proposal is to evaluate whether weaning from an incubator to a crib at lower versus higher weight, 1600g or 1800g will result in shorter length of hospital stay among moderately preterm infants. The hypothesis of this study is that length of hospital stay (from birth to discharge) will be decreased among moderate preterm infants weaned from an incubator to an open crib at a lower versus higher weight, 1600g vs. 1800g.
Primary Outcome
Number of days the infant stays in hospital after birth until discharge home (up to 120 days).
Interventions
- PROCEDURE Weaning from an incubator at a lower weight (1600 grams)
- PROCEDURE Weaning from an incubator at a higher weight (1800 grams)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 366 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02160002 record still lists
NCT02160002 is an interventional study that assigns participants to a tested intervention. The registered 366 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Weaning from an incubator at a lower weight (1600 grams) is the first listed.
NCT02160002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02160002 about?
NCT02160002 is a clinical study titled "Incubator Weaning of Moderately Preterm Infants". The objective of this proposal is to evaluate whether weaning from an incubator to a crib at lower versus higher weight, 1600g or 1800g will result in shorter length of hospital stay among moderately preterm infants. The hypothesis of this study is that length of hospital stay (from birth to discha...
What is the current status of trial NCT02160002?
This trial is currently completed. It is a NA study. The enrollment target is 366 participants. The study started on 2015-02. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02160002?
The interventions under investigation include: Weaning from an incubator at a lower weight (1600 grams) (PROCEDURE), Weaning from an incubator at a higher weight (1800 grams) (PROCEDURE).
Who is sponsoring clinical trial NCT02160002?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02160002's enrollment target sits among peer trials
366 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05083481 · 366 participants · Phase 1
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
- NCT05429632 · 366 participants · Phase 3
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- NCT06979453 · 366 participants · Phase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia